Multiple 10b5-1 sales by Alexis T. LeQuoc (DDOG) reported

Rhea-AI Filing Summary

Alexis T. LeQuoc reported multiple sales of Class A Common shares under Rule 144/10b5-1 arrangements. The filing lists repeated 10b5-1 sales between 02/11/2026 and 05/04/2026, including a 53,541-share sale on 03/02/2026 for $5,918,202.62. The record shows securities described as "Previously Exercised Stock Options" and cash settlements.

Insights

Corporate Governance Analyst

Routine insider disposals under prearranged plans, not an ad hoc sale pattern.

These entries document multiple scheduled 10b5-1 sales by Alexis T. LeQuoc, with individual transactions and cash proceeds listed. The filing characterizes the securities as Class A Common from "Previously Exercised Stock Options."

Timing is tied to the 10b5-1 plan mechanics; subsequent filings would show any changes to plan status or further transactions.

Key Figures

Sale on 03/02/2026: 53,541 shares Proceeds on 03/02/2026: $5,918,202.62 Sale on 05/04/2026: 32,418 shares +3 more

6 metrics

Sale on 03/02/2026 53,541 shares sale reported for 03/02/2026

Proceeds on 03/02/2026 $5,918,202.62 cash amount shown alongside 53,541 shares on 03/02/2026

Sale on 05/04/2026 32,418 shares 10b5-1 sale on 05/04/2026

Proceeds on 05/04/2026 $4,698,507.15 cash amount shown for 32,418 shares on 05/04/2026

Sale on 04/22/2026 43,224 shares 10b5-1 sale on 04/22/2026

Record of securities class Class A Common security type listed across transactions

Key Terms

10b5-1, Previously Exercised Stock Options, Class A Common

3 terms

10b5-1 regulatory

"10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Previously Exercised Stock Options financial

"Previously Exercised Stock Options | Issuer"

Class A Common market

"Class A Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10806	1585132.14	328274648	05/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/06/2023	Previously Exercised Stock Options	Issuer			10806	12/06/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	05/04/2026	32418	4698507.15
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	05/04/2026	10688	1549025.73
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	04/22/2026	43224	5655315.78
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	04/06/2026	21612	2516931.36
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	04/06/2026	10688	1244723.41
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	03/23/2026	32418	4141418.95
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	03/10/2026	43224	5424382.91
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	03/10/2026	10688	1341287.35
ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	03/02/2026	53541	5918202.62
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	02/23/2026	21612	2266660.08
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	02/11/2026	32418	4110310.64
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	02/11/2026	10688	1355142.21

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DDOG Form 144 say about Alexis T. LeQuoc's sales?

The Form 144 lists multiple 10b5-1 sales by Alexis T. LeQuoc of Class A Common shares. The entries show individual sale dates, share counts, and cash proceeds for each transaction between February and May 2026.

How many shares were sold on March 2, 2026, per the filing?

The filing reports a sale of 53,541 shares on March 2, 2026 for $5,918,202.62. This is one listed transaction among several under 10b5-1 arrangements in the excerpt.

Were the sold shares from option exercises or open‑market holdings?

The filing labels the securities as "Previously Exercised Stock Options," indicating the shares originated from option exercises and were sold for cash under the reported transactions.

Does the Form 144 state proceeds or values for each sale?

Yes. Each listed sale in the excerpt includes a cash amount alongside the share count, for example $4,698,507.15 for 32,418 shares on May 4, 2026, and other per-transaction proceeds.